Premium
Sodium 1, 4‐dihydroxy‐9, 10‐anthraquinone‐ 2‐sulphonate interacts with calf thymus DNA in a way that mimics anthracycline antibiotics: an electrochemical and spectroscopic study
Author(s) -
Guin Partha Sarathi,
Das Saurabh,
Mandal P. C.
Publication year - 2010
Publication title -
journal of physical organic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.325
H-Index - 66
eISSN - 1099-1395
pISSN - 0894-3230
DOI - 10.1002/poc.1624
Subject(s) - chemistry , anthracycline , intercalation (chemistry) , daunorubicin , anthraquinone , binding constant , dna , anthraquinones , electrochemistry , molecule , stereochemistry , sodium , combinatorial chemistry , binding site , organic chemistry , biochemistry , cancer , chemotherapy , medicine , botany , surgery , electrode , breast cancer , biology
The anthracycline drugs, adriamycin and daunorubicin, efficient in the treatment of various human cancers, form strong intercalation complexes with DNA. The therapeutic efficiency and toxic properties of the drugs are associated with electron transfer processes, which correlate well with the redox behaviour of the compounds. Sodium 1,4‐dihydroxy 9,10‐anthraquinone‐2‐sulphonate (sodium quinizarin‐2‐sulphonate, NaLH 2 ) (Na‐Qz‐2S) is a molecule that resembles anthracycline drugs and has a simpler structure in comparison to these drugs. Two electrons in the course of chemical action reduce this molecule like the anthracyclines. Electrochemical methods were used to identify this process. UV‐Vis and fluorescence spectroscopy were used to analyse binding of the compound to calf thymus DNA. The binding constant and site size were evaluated for Na‐Qz‐2S and the same compared to that of the anthracyclines. Such comparisons are essential in order to understand whether the simpler hydroxy‐anthraquinones can be a substitute for anthracycline drugs in cancer chemotherapy. Copyright © 2009 John Wiley & Sons, Ltd.